In this presentation from Pediatric Ophthalmology Subspecialty Day 2022, Dr. Benjamin Ticho provides an update on the use of low-dose atropine eyedrops to slow the progression of myopia in children. He highlights what we currently do and do not know about this treatment option. Topics include the following:

• older and newer studies: ATOM1, ATOM2, LAMP, MTS1, and Sydnexis STAAR
• atropine's mechanism of action
• nonresponders and the rebound effect
• choroidal thickness as a biomarker
• racial differences in atropine response
• combination therapy with atropine and orthokeratology